Press Releases

Vancouver, British Columbia--(Newsfile Corp. - April 30, 2024) - Nexus Uranium Corp. (CSE: NEXU) (OTCQB: GIDMF) (FSE: 3H1) (the "Company" or "Nexus") is pleased to announce that it has completed its previously announced private placement of 2,400,000 units ("Units") at a price of $0.50 per Unit to raise gross proceeds of $1,200,000 (the "Private Placement").

Each Unit consists of one common share (a "Common Share") and one common share purchase warrant (a "Warrant").... (continue reading...)

Dr. Yuan-Shiun Chang from Taiwan, Dr. Laurie Carpenter Dolan from the United States, and Professor Nah Seung-Yeol from Korea announce scientific research on Korean red ginseng consumption.

CERRITOS, Calif., April 30, 2024 /PRNewswire/ -- Korea Ginseng Corp. US (KGCUS) aka JungKwanJang held a dedicated international seminar session on "Korean Ginseng: Safety, Efficacy And Neuroprotective Insights'' at the International Conference on the Science of Botanicals (ICSB)... (continue reading...)

VANCOUVER, British Columbia, April 30, 2024 (GLOBE NEWSWIRE) -- Liberty Gold Corp. (TSX:LGD; OTCQX: LGDTF) (“Liberty Gold” or the “Company”) is pleased to announce the successful upsizing of its non-brokered, private placement financing from C$9.5 million to C$12.5 million (the “Offering”).

The terms of the Offering remain unchanged and will consist of the issuance of up to 35,715,362 units of the Company (the “Units”) at an issue price of... (continue reading...)

DALLAS, April 30, 2024 /PRNewswire/ -- Ashford Hospitality Trust, Inc. (NYSE: AHT) ("Ashford Trust" or the "Company") today announced its preliminary expectations for net income attributable to common stockholders, Adjusted EBITDAre, and Adjusted FFO for the first quarter ended March 31, 2024.

The Company reported today a preliminary estimated range of net income attributable to common stockholders of approximately $66.4 million to $68.4 million or $0.59 to $0.61 per... (continue reading...)

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Sarepta Therapeutics, Inc. (NASDAQ: SRPT), the leader in precision genetic medicine for rare diseases, granted equity awards on April 30, 2024 that were previously approved by the Compensation Committee of its Board of Directors under Sarepta’s 2024 Employment Commencement Incentive Plan, as a material inducement to employment to 24 individuals hired by Sarepta in April 2024. The equity awards were approved in accordance with... (continue reading...)